当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析 - 现金流量表

惠泰医疗

(688617)

  

流通市值:433.84亿  总市值:433.84亿
流通股本:1.41亿   总股本:1.41亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,348,601,398.07634,320,372.212,262,516,479.491,664,312,497.91
  收到的税费返还5,671,213.235,671,213.237,064,970.285,436,119.71
  收到其他与经营活动有关的现金44,101,599.5621,675,282.8951,843,236.9732,795,756.65
  经营活动现金流入小计1,398,374,210.86661,666,868.332,321,424,686.741,702,544,374.27
  购买商品、接受劳务支付的现金212,426,422.92108,809,971.49445,103,921.6340,029,735.98
  支付给职工以及为职工支付的现金363,668,530.68236,479,893.56545,483,989.29424,613,716.97
  支付的各项税费158,840,953.7162,552,788.97257,742,537.22178,942,624.03
  支付其他与经营活动有关的现金218,789,650.6287,161,626.82329,704,227.65235,120,874.94
  经营活动现金流出小计953,725,557.93495,004,280.841,578,034,675.761,178,706,951.92
  经营活动产生的现金流量净额444,648,652.93166,662,587.49743,390,010.98523,837,422.35
二、投资活动产生的现金流量:
  收回投资收到的现金1,210,078,765.88695,000,0002,374,900,000255,904,444.44
  取得投资收益收到的现金2,811,829.371,565,764.868,006,327.644,813,493.97
  处置固定资产、无形资产和其他长期资产收回的现金净额42,330-603,500424,000
  收到的其他与投资活动有关的现金--101,052,777.78101,052,777.78
  投资活动现金流入小计1,212,932,925.25696,565,764.862,484,562,605.42362,194,716.19
  购建固定资产、无形资产和其他长期资产支付的现金156,864,010.459,584,702.92650,244,936.13557,926,383.5
  投资支付的现金1,322,000,000685,000,0002,352,109,422582,009,155.44
  支付其他与投资活动有关的现金--100,000,000100,000,000
  投资活动现金流出小计1,478,864,010.4744,584,702.923,102,354,358.131,239,935,538.94
  投资活动产生的现金流量净额-265,931,085.15-48,018,938.06-617,791,752.71-877,740,822.75
三、筹资活动产生的现金流量:
  吸收投资收到的现金20,873,979.28-78,533,523.5269,759,005.08
  取得借款收到的现金4,000,000---
  收到其他与筹资活动有关的现金2,500,000-12,500,000-
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计27,373,979.28-91,033,523.5269,759,005.08
  偿还债务支付的现金591,000295,50071,182,00070,886,500
  分配股利、利润或偿付利息支付的现金170,250,745.135,415.44133,970,528.86133,961,840.33
  支付其他与筹资活动有关的现金53,224,424.282,555,980.61193,779,918.1185,310,225.57
  筹资活动现金流出小计224,066,169.412,856,896.05398,932,446.96390,158,565.9
  筹资活动产生的现金流量净额-196,692,190.13-2,856,896.05-307,898,923.44-320,399,560.82
四、汇率变动对现金及现金等价物的影响2,149,549.56799,616.44-13,002,729.01-2,474,689.05
五、现金及现金等价物净增加额-15,825,072.79116,586,369.82-195,303,394.18-676,777,650.27
  加:期初现金及现金等价物余额1,081,087,911.031,081,087,911.031,276,391,305.211,276,391,305.21
  期末现金及现金等价物余额1,065,262,838.241,197,674,280.851,081,087,911.03599,613,654.94
补充资料:
  净利润418,900,671.88-658,167,740.72-
  资产减值准备3,698,807.74-24,627,584.36-
  固定资产和投资性房地产折旧45,656,073.09-71,008,646.84-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧45,656,073.09-71,008,646.84-
  无形资产摊销6,951,793.65-6,374,411.13-
  长期待摊费用摊销828,670.31-3,599,514.48-
  处置固定资产、无形资产和其他长期资产的损失1,318.95--253,318.97-
  固定资产报废损失133,527.18-833,313.87-
  公允价值变动损失-250,472.99---
  财务费用-1,677,906.79-6,890,960.44-
  投资损失-7,896,662.55--13,170,904.11-
  递延所得税-2,224,916.32--15,131,114.97-
  其中:递延所得税资产减少-2,845,399.91--16,707,806.04-
    递延所得税负债增加620,483.59-1,576,691.07-
  存货的减少-42,611,877.14--79,290,763.44-
  经营性应收项目的减少-179,897.9--74,725,517.7-
  经营性应付项目的增加32,630,221.13-134,474,630.51-
  其他-15,537,675.15-7,237,369.6-
  现金的期末余额1,065,262,838.24-1,081,087,911.03-
  减:现金的期初余额1,081,087,911.03-1,276,391,305.21-
  现金及现金等价物的净增加额-15,825,072.79--195,303,394.18-
公告日期2025-08-222025-04-232025-04-232024-10-26
审计意见(境内)标准无保留意见
TOP↑